Literature DB >> 8990052

The neurological syndrome of infantile cobalamin deficiency: developmental regression and involuntary movements.

P J Grattan-Smith1, B Wilcken, P G Procopis, G A Wise.   

Abstract

Developmental regression is the presenting symptom of most infants with cobalamin (Vitamin B12) deficiency. We present a report of three infants with cobalamin deficiency in which the infants also developed a movement disorder. In each case the mother was a vegetarian and the infant was exclusively breast-fed. In two of the infants, a striking movement disorder consisting of a combination of tremor and myoclonus particularly involving face, tongue, and pharynx appeared 48 h after the initiation of treatment with intramuscular cobalamin. This was associated with marked changes in plasma amino acid levels. Paradoxically, the onset of the movement disorder coincided with overall neurological improvement. The third infant had a persistent focal tremor, which appeared before the commencement of treatment. The movements slowly abated during a 3-6 week period. The presence of a movement disorder in cobalamin deficiency has received less attention than other features, but in a mild form is probably common. It may offer an early clue to the diagnosis before the onset of profound neurological deterioration. The cause of the severe movement disorder that can appear after treatment is not known.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990052     DOI: 10.1002/mds.870120108

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Megaloblastic anemia: back in focus.

Authors:  Jagdish Chandra
Journal:  Indian J Pediatr       Date:  2010-06-29       Impact factor: 1.967

Review 2.  Cobalamin status in children.

Authors:  Anne-Lise Bjørke-Monsen; Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

3.  Infantile Tremor Syndrome or a Neurocutaneous Infantile B12 Deficiency (NIB) Syndrome?

Authors:  Himanshi Chaudhary; Savita Verma; Prateek Bhatia; Pankaj C Vaidya; Pratibha Singhi; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2020-01-27       Impact factor: 1.967

4.  Knuckle pigmentation, peripheral neuropathy, madness and abnormal movement: is it B12 deficiency?

Authors:  Sanjeev Kumar Bhoi; Menka Jha; Suprava Naik; Gayatri Devi Palo
Journal:  Neurol Sci       Date:  2019-05-14       Impact factor: 3.307

5.  Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.

Authors:  S Jill James; Stepan Melnyk; Stefanie Jernigan; Mario A Cleves; Charles H Halsted; Donna H Wong; Paul Cutler; Kenneth Bock; Marvin Boris; J Jeffrey Bradstreet; Sidney M Baker; David W Gaylor
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

6.  Infantile tremor syndrome in Iraqi Kurdistan.

Authors:  Nazar M Mohammad Amin; Jamal Mohammad Zeki
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

7.  Frontotemporal Atrophy: Presenting Sign in Infantile Cobalamin Deficiency.

Authors:  Pallavi Vats; Prashant Verma; Bijo Varughese; Somesh Kumar; Seema Kapoor
Journal:  Indian J Pediatr       Date:  2017-11-23       Impact factor: 1.967

8.  High frequency of maternal vitamin B12 deficiency as an important cause of infantile vitamin B12 deficiency in Sanliurfa province of Turkey.

Authors:  Ahmet Koc; Abdurrahim Kocyigit; Mustafa Soran; Nihat Demir; Eylem Sevinc; Ozcan Erel; Zeki Mil
Journal:  Eur J Nutr       Date:  2006-04-06       Impact factor: 5.614

Review 9.  Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment.

Authors:  Yuanyuan Xiang; Lei Li; Xiaotong Ma; Shan Li; Yuan Xue; Peng Yan; Meijie Chen; Junwei Wu
Journal:  Neurotox Res       Date:  2021-03-26       Impact factor: 3.911

10.  Methylmalonic acid values in healthy Dutch children.

Authors:  Marije Hogeveen; Ingrid van Beynum; Arno van Rooij; Leo Kluijtmans; Martin den Heijer; Henk Blom
Journal:  Eur J Nutr       Date:  2007-12-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.